{
  "report_rows": [
    {
      "kpi": "Non-GAAP diluted EPS (Q2'26)",
      "prediction": "BEAT",
      "answer": "pred ~$5.90 vs. cons $5.77",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales (Q2'26)",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.58B vs. cons ~$1.575B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP operating margin (Q2'26)",
      "prediction": "BEAT",
      "answer": "pred ~22.6% vs. cons ~22.2%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 non-GAAP EPS guide (raise)",
      "prediction": "BETTER",
      "answer": "guide ~$24.10\u201324.40 (mid ~$24.25) vs. cons ~$24.05 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3'26 non-GAAP EPS initial guide",
      "prediction": "LOWER",
      "answer": "guide ~$6.05 vs. cons ~$6.15 (Q3 2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Digital Imaging non-GAAP op margin (toward 24% target)",
      "prediction": "BETTER",
      "answer": "guide/print ~23.6% vs. cons ~23.4% (FY2026 exit)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "Likely another beat-and-raise (EPS above the $5.70\u20135.80 guide, FY lifted toward/above $24.15), which should drive an initial +2% pop. But shares are +25% YTD, near the top of their range, and already ran +3.3% into the print, so much is priced. The Q2 guide already embedded an atypical sequential EPS decline, and the initial Q3 guide is likely conservative/below consensus; with a tough Q2'25 comp (tariff pull-forward) capping organic upside, out-period estimates get only modestly revised up. That out-period math plus elevated valuation makes the day-1 gain partially fade, as it did after the Q1 print (656 -> low-600s).",
  "day5_confidence": "MEDIUM"
}